HYDROCODONE BITARTRATE AND ACETAMINOPHEN (Page 3 of 3)

DOSAGE AND ADMINISTRATION

Dosage should be adjusted according to the severity of the pain and the response of the patient. However, it should be kept in mind that tolerance to hydrocodone can develop with continued use and that the incidence of untoward effects is dose related.

The usual adult dosage is one tablet every four to six hours as needed for pain. The total daily dosage should not exceed 5 tablets.

HOW SUPPLIED

Hydrocodone bitartrate and acetaminophen tablets USP, 7.5 mg/750 mg are white, capsule shaped tablets debossed with “Image from Drug Label Content”, “568” on one side and scored on the other side.

Bottles of 100 Tablets NDC 62037-568-01

Bottles of 500 Tablets NDC 62037-568-05

Storage: Store at controlled room temperature, 20 to 25°C (68 to 77°F) with excursions permitted to between 15 to 30°C (59 to 86°F) [see USP].

Dispense in a tight, light-resistant container as defined in the USP.

A Schedule CIII Controlled Drug Substance.

Manufactured by:
Andrx Pharmaceuticals, Inc.
Fort Lauderdale, FL 33314

Rev date: 06/07
7279

HYDROCODONE BITARTRATE AND ACETAMINOPHEN
hydrocodone bitartrate and acetaminophen tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:62037-568
Route of Administration ORAL DEA Schedule CIII
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Hydrocodone Bitartrate (Hydrocodone) Hydrocodone 7.5 mg
Acetaminophen (Acetaminophen) Acetaminophen 750 mg
Inactive Ingredients
Ingredient Name Strength
colloidal silicon dioxide
corn starch (pregelatinized)
croscarmellose sodium
crospovidone
magnesium stearate
microcrystalline cellulose
povidone
stearic acid
Product Characteristics
Color white (WHITE) Score 2 pieces
Shape OVAL (Oval) Size 19mm
Flavor Imprint Code 568
Contains
Coating false Symbol true
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:62037-568-01 100 TABLET (100 TABLET) in 1 BOTTLE None
2 NDC:62037-568-05 500 TABLET (500 TABLET) in 1 BOTTLE None
Labeler — Andrx Pharmaceuticals, Inc.

Revised: 07/2008 Andrx Pharmaceuticals, Inc.

Page 3 of 3 1 2 3

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.